Gyne-Lotrimin
Gyne-Lotrimin Price range: $ 40,00 through $ 63,00
Back to products
HardOn Oral Jelly
HardOn Oral Jelly Price range: $ 62,00 through $ 147,00

Hair Loss Cream

Price range: $ 94,00 through $ 171,00

Hair Loss Cream is a specialized topical solution designed to effectively combat thinning and promote a fuller appearance. This advanced formula works by nourishing the scalp and strengthening hair follicles right at the root. Regular application helps to significantly reduce daily hair shedding while encouraging the revitalization of dormant strands. The lightweight texture ensures quick absorption without leaving any greasy residue, making it ideal for daily grooming routines. Consistent use of this cream leads to visibly thicker, stronger, and more resilient hair for both men and women.

Active substance: Herbal
SKU: Hair Loss Cream Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Hair Loss Cream belongs to a category of dermatological formulations designed for direct topical application to the scalp. The preparation is primarily utilized to address pattern hair loss (androgenetic alopecia) in adult patients experiencing progressive follicle miniaturization. Dispensed in accordance with applicable federal and state regulations, this topical therapy requires consistent daily administration to maintain therapeutic outcomes.

Topical scalp formulations are specifically engineered to deliver active pharmaceutical ingredients directly to hair follicles while minimizing systemic exposure throughout the body. Successful management of hair thinning depends on correct scalp preparation, continuous long-term application, and realistic expectations regarding follicle reactivation timelines.

Property Description
Primary Purpose Management of hereditary pattern hair thinning (androgenetic alopecia)
Route of Administration Topical application strictly to intact scalp skin
Application Frequency Typically applied twice daily (morning and evening)
Prescription Status Dispensed in accordance with applicable federal and state regulations
Storage Requirements Store at 20°C to 25°C (68°F to 77°F); protect from excessive heat
Onset of Visible Effect Gradual; initial evaluation typically at 3 to 6 months

Mechanism of Action and Clinical Overview

How the drug works

Topical formulations for scalp hair loss act locally on cutaneous microvasculature and follicular receptors. By prolonging the anagen (growth) phase of the hair growth cycle and shortening the telogen (resting) phase, the treatment stimulates miniaturized hair follicles to transition back into active keratin production. Localized application increases cutaneous blood flow around the follicular bulb, enhancing the delivery of oxygen and metabolic nutrients essential for hair shaft development. Systemic exposure remains minimal when the cream is applied strictly to intact, healthy scalp tissue without transepidermal barrier disruption.

Main uses

Topical Hair Loss Cream is indicated for the management of androgenetic alopecia in adult men and women presenting with gradual hair thinning on the vertex or frontal scalp regions. Clinical utility is restricted to non-cicatricial (non-scarring) alopecia where hair follicles remain viable and biologically responsive to pharmacological stimulation. It is not indicated for sudden or patchy hair loss caused by autoimmune conditions such as alopecia areata, post-partum telogen effluvium, nutritional deficiencies, or chemotherapy-induced alopecia. Accurate dermatological diagnosis is essential prior to initiating therapy to confirm that the underlying hair loss etiology is responsive to topical intervention. Any off-label application for non-scalp body hair enhancement is explicitly not recommended due to a lack of safety and efficacy data.

Dosing schedule

Topical administration requires strict adherence to recommended daily application guidelines to achieve optimal therapeutic outcomes. The standard regimen involves applying a thin layer (typically a measured quantity or approximately 1 gram) twice daily directly to dry scalp tissue in areas experiencing visible hair thinning. The scalp and hair must be thoroughly washed and dried before applying the product. Users should massage the cream gently into the target scalp areas using their fingertips, followed immediately by thorough hand washing with soap and water to prevent accidental transfer to non-target dermal sites. Total daily dosage should not exceed the recommended amount, as increasing application volume or frequency does not accelerate hair regrowth and significantly increases the risk of systemic adverse reactions.

How it’s absorbed and eliminated

Following topical scalp application, systemic absorption of the active constituent remains low under normal clinical conditions. Approximately 1% to 2% of the total applied topical dose enters systemic circulation through intact cutaneous tissue. Peak systemic drug concentrations occur gradually over several hours post-application. The small fraction that enters circulation undergoes hepatic clearance into inactive metabolites, which are subsequently excreted via the renal system. The systemic clearance half-life of the absorbed fraction ranges between several hours, although local biological activity within the dermal matrix persists longer due to tissue binding. Alterations in skin integrity, such as scalp psoriasis, severe sunburn, or abrasions, can markedly increase transepidermal absorption and elevated drug plasma levels.

Compatibility with other medicines

Concomitant application of other topical medications or cosmetic scalp products during treatment requires careful clinical consideration. Co-administration with topical corticosteroids, retinoids, or petrolatum-based ointments can alter epidermal permeability and increase systemic absorption of the hair loss formulation. While systemic drug interactions are rare due to low systemic bioavailability, caution is advised in patients concurrently taking oral antihypertensive agents or systemic vasodilators, as additive blood pressure reductions could theoretically occur if excessive dermal absorption takes place. Patients should avoid applying other medicated scalp preparations simultaneously unless explicitly directed by a prescribing clinician or pharmacist.

Safety Profile and Important Precautions

Adverse reactions

Cutaneous adverse events represent the most commonly observed side effects associated with topical hair loss treatments. Localized reactions include mild scalp irritation, localized pruritus, contact dermatitis, dryness, and desquamation at the site of application. Unwanted facial hypertrichosis (hair growth) may occur if the cream is accidentally transferred to forehead or cheek skin during application or transfer from bedding. Less frequent systemic side effects, which typically signal excess systemic absorption, include dizziness, lightheadedness, mild headache, fluid retention, or localized peripheral edema. Discontinuation of application generally leads to the resolution of local dermatological complaints, though hair regrowth gained during therapy will gradually revert to pre-treatment levels within three to four months following treatment cessation.

Important precautions

Topical Hair Loss Cream should be used with caution in individuals with pre-existing cardiovascular conditions, including coronary artery disease, cardiac arrhythmias, or uncontrolled hypertension. Occlusive dressings, wraps, or plastic caps must never be applied over treated areas unless specifically directed by a healthcare professional. The safety and effectiveness of this preparation have not been established in pediatric patients under 18 years of age. Pregnant or nursing individuals should avoid handling or applying hair loss formulations containing androgen-modulating or vasodilating active ingredients due to potential risks to fetal development. Patients who experience persistent local inflammation or signs of systemic absorption should suspend treatment and consult a medical professional at a clinical center in their area, such as a dermatology clinic in Chicago or Texas.

Warning Sign / Red Flag Recommended Action
Facial swelling, lip edema, or severe rash Discontinue use immediately and seek emergency medical care
Chest pain, rapid heartbeat, or palpitations Seek urgent medical evaluation at an emergency facility
Persistent severe scalp burning or blistering Stop application, wash scalp thoroughly, and contact a provider
Unexplained sudden weight gain or leg edema Suspend treatment and consult your primary care clinician
Severe dizziness, lightheadedness, or fainting Discontinue use and seek prompt medical attention

First days of treatment

During the initial two to six weeks of therapy, patients often observe a transient increase in hair shedding. This temporary shedding phase occurs as miniaturized telogen hairs are pushed out by newly developing anagen hair shafts emerging from reactivated follicles. Patients should understand that early shedding is typically a predictable physiological indicator of follicular cycling rather than a sign of treatment failure. Visible cosmetic improvement generally requires uninterrupted daily application for at least three to four months before noticeable hair density increases occur.

Signs of improvement

Evaluating clinical response requires patient observation over an extended treatment period. The preliminary sign of therapeutic efficacy is usually the stabilization or reduction of ongoing hair shedding. Subsequent progress manifests as the emergence of fine, soft downy hairs (vellus hair) within the targeted thinning scalp regions. With continued compliant twice-daily use, these fine hairs may gradually thicken, lengthen, and darken into mature terminal hairs. If no measurable improvement in hair density or shedding stabilization is observed after six months of consistent application, treatment efficacy should be formally re-evaluated by a clinician.

If you skip a dose

If an application is forgotten, the user should apply the regular dose as soon as remembered on that day. However, if it is nearly time for the next scheduled application, skip the missed dose entirely and resume the standard twice-daily dosing routine. Patients should never double the applied dose or increase the amount of cream to compensate for missed applications. Over-applying the product does not accelerate hair regrowth and increases the likelihood of localized cutaneous irritation and systemic adverse effects.

Storage and expiration

Store Hair Loss Cream at controlled room temperature between 20°C and 25°C (68°F to 77°F), away from direct sunlight, excess heat, and high humidity. Keep the tube or container tightly closed when not in use to prevent formulation evaporation or active ingredient degradation. Do not freeze the product or store it in moist bathroom cabinets. Keep the medication safely out of the reach and sight of children and household pets. Expired or unused cream should be disposed of in accordance with local community pharmacy take-back programs or FDA drug disposal guidance.

Common questions

How long must Hair Loss Cream be used to maintain results?

Topical treatments for androgenetic alopecia require ongoing, continuous application to sustain hair regrowth benefits. Hair loss is a progressive, genetically influenced condition, and halting application causes reactivated follicles to return to their baseline miniaturization process. Discontinuing treatment usually leads to the progressive loss of newly regrown hair within three to four months.

Can hair dyes or styling products be used during treatment?

Cosmetic hair products, dyes, or perm chemicals may generally be used during treatment, provided specific routine precautions are followed. The scalp should be completely free of topical cream prior to applying chemical hair treatments. Additionally, hair loss cream should not be applied for at least 24 hours after chemical scalp procedures to prevent severe localized irritation.

What should be done if the cream gets into the eyes or on broken skin?

If accidental contact occurs with sensitive mucosal membranes, inflamed skin, or eyes, the affected area should be flushed immediately with copious amounts of cool, clean water. Persistent ocular burning, redness, or visual disturbance warrants prompt consultation with an eye specialist or emergency healthcare provider.

Is it acceptable to wear a hat or sleep right after application?

Patients should allow the applied cream to dry completely for at least 15 to 30 minutes before wearing hats, headbands, or lying down on pillows. Allowing the formulation to dry thoroughly prevents the product from rubbing off onto fabrics, ensuring maximum dermal absorption and reducing accidental transfer to facial skin.

Will applying the cream more than twice daily produce faster results?

Applying the product more frequently than recommended does not enhance or accelerate hair growth outcomes. The epidermal layer has a limited capacity to absorb topical formulations, and excessive application merely increases systemic exposure, raising the risk of scalp dermatitis, headaches, and cardiovascular side effects.

This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA guidelines, topical treatments for hair loss should be used strictly as directed.

Additional information
Dosage

50 ml

Package

1 tubes

,

2 tubes

Ενεργός Ουσία